U-M Health Board

Santa J. Ono, Ph.D., is the 15^th president of the University of Michigan. A recognized leader in higher education in the United States and Canada, he an experienced vision researcher whose pioneering work in experimental medicine focuses on the immune system and eye disease. At U-M he is professor of ophthalmology and visual sciences in the Medical School.

He joined U-M from the University of British Columbia, where he served as president and vice chancellor. Prior to UBC, he was president of the University of Cincinnati, where he also served as professor of pediatrics at Cincinnati Children’s Hospital Medical Center. He has served as senior vice provost and deputy to the provost at Emory University. He also has taught at Johns Hopkins University, Harvard University and University College London.

He holds a B.A. in biological sciences from the University of Chicago and a Ph.D. in experimental medicine from McGill University.

Marshall S. Runge, M.D., Ph.D., is executive vice president for Medical Affairs at the University of Michigan, Dean of the Medical School, and CEO of Michigan Medicine. Prior to joining the University of Michigan in March 2015, he was executive dean and chair of the Department of Medicine at the UNC School of Medicine. He was also principal investigator and director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at UNC-Chapel Hill. Before joining the UNC faculty in 2000, Dr. Runge held the John Sealy Distinguished Chair in Internal Medicine and was director of the Division of Cardiology and the Sealy Center for Molecular Cardiology at the University of Texas Medical Branch at Galveston.

Dr. Runge earned his doctorate in molecular biology at Vanderbilt University and his medical degree from Johns Hopkins School of Medicine, where he also completed a residency in internal medicine. He was a cardiology fellow and faculty member at Harvard’s Massachusetts General Hospital before joining Emory University as an associate professor of medicine in 1989.

Dr. David Miller has served as President, University of Michigan Health and Executive Vice Dean for Clinical Affairs, University of Michigan Medical School since January 1, 2021. U-M Health is composed of C.S. Mott Children's Hospital, the Von Voigtlander Women's Hospital, University Hospital, Frankel Cardiovascular Center, and the University of Michigan Medical Group, including 2,000 physicians, and 140 clinics at 40 sites throughout Southeastern Michigan. In this role, Dr. Miller oversees all activities of the health system that serves patients from throughout Michigan and around the world.

Dr. Miller served as Chief Clinical Officer for University Hospital and the Frankel Cardiovascular Center from 2018-2020. Working in partnership with the Chief Operating Officer and Chief Nursing Officer, Dr. Miller provided clinical operational leadership to ensure quality and safety in clinical programs and patient care, improve patient experience, enhance staff engagement, and optimize capacity management within the two adult hospitals.

Dr. Miller is a Professor in the Department of Urology and maintains a clinical practice that focuses on the diagnosis and management of patients with prostate cancer.

In addition to his clinical practice, Dr. Miller served as Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC) 2011 through 2020. Funded by Blue Cross Blue Shield of Michigan (BCBSM), MUSIC is a consortium of more than 40 urology practices aiming to improve the quality and cost-efficiency of urological care in the state of Michigan.

Dr. Miller also has a broad background in health services research, including substantial experience using claims data and formal training in the advanced statistical methods used in observational data analyses. With prior funding from the Agency for Healthcare Research & Quality and the National Cancer Institute, Dr. Miller's empirical research agenda focused on comparative effectiveness research, physician-led collaborative quality improvement, and understanding the relationship between physician organizations, integrated delivery systems, and the quality and cost of specialty care.

Kedrick D. Adkins, Jr., is the former Chief Financial Officer for the Mayo Clinic, where he was directly responsible for Contracting and Payer Relations; Enterprise Revenue Cycle; Finance in Arizona, Florida and the Midwest; Financial and Accounting Services; Mayo Clinic Ventures; Supply Chain Management; and Treasury. Prior to the Mayo Clinic, Kedrick served seven years as president of Integrated Services for Trinity Health, providing oversight of the complete span of finance, treasury, information technology, supply chain management, operations, performance leadership, insurance and risk management, integration services, and payer and product innovation across the 10 states in which Trinity Health operated. Prior to that, Kedrick spent 30 years at Accenture, a global management consulting firm, where he held roles as global managing partner for the Health Care Practice, global chief diversity officer and country managing director, U.S. Operations.

Kedrick holds an MBA in Finance and Accounting and a B.S. in Industrial and Operations Engineering from the University of Michigan, Ann Arbor.

 

Victor Dzau is President of National Academy of Medicine, Vice Chair of the National Research Council, Chancellor Emeritus of Duke University, and past CEO of Duke Health System. Previously, he was Professor and Chairman of Medicine at both Harvard and Stanford Universities. Dr. Dzau is recognized globally for a long and highly decorated career as a scientist, administrator, and leader.

He is known for his seminal work on the renin–angiotensin system and pioneering research in gene therapy for vascular disease. His research laid the foundation for development of lifesaving drugs known as ACE inhibitors, used globally to treat high blood pressure and congestive heart failure. Dr. Dzau has served on the Advisory Committee to NIH Director and chaired the NIH Cardiovascular Disease Advisory Committee.

Dr. Dzau serves as inaugural president of NAM and led its transition from the Institute of Medicine. At NAM, he leads a strategy of innovation and equity. Under his tenure, the NAM has launched important initiatives including the Global Health Risk Framework, the Human Genome Editing Initiative, the Action Collaborative on Clinician Well-Being and Resilience, the Healthy Longevity Grand Challenge, and the Grand Challenge in Climate Change and Health. Dr Dzau is a leader in academic medicine.

He has served as Chair of the Board of Directors for the Association of Academic Health Centers. His vision is for Academic Health Centers (AHCs) to lead the transformation of medicine, as system integrators with regards to innovation, translation, implementation, and globalization. He has proposed a new AHC model: Bench to Bedside to Population to Society. Leading this initiative at Duke, he worked with other to develop the Duke Translational Medicine Institute, Duke Global Health Institute, Duke Institute of Health Innovation and Duke- National University of Singapore Graduate Medical School.

Dr. Dzau serves or has served on the boards of multiple AHCs including Stanford Health System, Partners (Mass General Brigham) Healthcare System, Duke University Health System, SingHealth Services, Imperial College Health Partners, and the Governing Board of the Duke NUS Graduate Medical School.Among his many honors and recognitions are the Gustav Nylin Medal from the Swedish Royal College of Medicine, the Research Achievement Award from the American Heart Association, and the Poulzer Prize of the European Academy of Sciences and Arts.

He is a member of the American Academy of Arts and Sciences, the Japan Academy, the Royal Society of Medicine, and the European Academy of Sciences and Arts. Dr. Dzau has received 16 honorary doctorates and was made an honorary Citizen of Singapore, the highest honor bestowed to a foreign individual.

Dr. Fenner is the Chair and Bates Professor of Diseases of Women and Children at the University of Michigan.  She attended undergraduate and medical school at the University of Missouri – Columbia.  She completed a residency in Obstetrics and Gynecology at the University of Michigan followed by a fellowship in Pelvic Surgery and Urogynecology at the Mayo Clinic -Scottsdale.   

She is nationally recognized as an expert in defecation disorders, surgical education, and reconstructive surgery.   Working with a multidisciplinary team, her major contributions have been on understanding how birth injuries impact pelvic floor disorders and developing new and novel treatments for accidental bowel leakage. She has received NIH support over the past 20 years and published more than 100 peer-reviewed articles and chapters.

She is the Past-President of the Association of Professors of Obstetrics and Gynecology, the American Urogynecologic Society, and the American Gynecological and Obstetrical Society. As Director of the Female Pelvic Medicine and Reconstructive Surgery Board for the American Board of Obstetrics and Gynecology and the American Board of Urology, she was instrumental in obtaining recognition of the subspecialty, Female Pelvic Medicine and Reconstructive Surgery, from the American Board of Medical Subspecialties and ACGME. 

Throughout her career she has been a champion for the inclusion and advancement of women in medicine and leadership.  Dr. Fenner has received numerous awards for her contributions as a physician surgeon, educator, and leader.  In 2014 she was given the Sarah Goddard Award by the University of Michigan for Leadership in the advancement of women. She was recognized with the Lifetime Achievement Awards from the American Urogynecologic Society and in 2015 and in 2017 from the Association of Professors of Gynecology and Obstetrics Lifetime Achievement Award. In 2019 she received the Rudi Ansbacher Leadership Award for Support of Women in Healthcare.

 

Tiffany Ford is the President and CEO of the University of Michigan Credit Union. Ford joined the University of Michigan Credit Union in 2011. Under her leadership, the University of Michigan Credit Union has grown significantly in membership and asset size. The Credit Union has also won multiple local and national awards for talent development and products and

services. Prior to joining the University of Michigan Credit Union Ford served in senior management for over 11 years at Michigan State University Federal Credit Union. Ford served as Assistant Vice President of Internal Audit, Vice President of Contact Center, Vice President of Finance and Executive Vice President.

Prior to her financial institution experience, Ford began her career as a staff auditor for public accounting firm Plante Moran. Ford is a Certified Public Accountant and earned a Bachelor’s of Arts degree from Michigan State University and a Master’s of Business Administration degree from Michigan State University.

Ford has earned the Michigan Ross Distinguished Leader Executive Certificate through the University of Michigan and has completed the Harvard Business School Women in Business Executive Education Program. A native of Detroit, Michigan, Tiffany and her husband reside in Metropolitan Detroit with their three children. Ford is an active volunteer in her community and serves on the Board of Word In Action Christian Center International. Ford is a Board Member of Credit Union Executive Society (CUES), Ann Arbor Spark, and Culture Source.

Ford also serves as a member of the Michigan Medicine Advisory Group. Ford previously served as a Board member of the University Musical Society.

Ford served on the Michigan Credit Union League Committee who worked with the State of Michigan to update the Michigan Credit Union Act. Ford was named Professional of the Year by the Michigan Credit Union League.

Patricia D. Hurn is the current dean of the University of Michigan School of Nursing. Previously, she served as a vice chancellor for research and innovation at the University of Texas System. Dr. Hurn has received more than $20 million in NIH funding as a principal investigator. She is a global leader in research focused on understanding the cellular and molecular basis of gender differences in brain injuries, as well as stroke and other neurological conditions. Much of Dr. Hurn’s work as a researcher and health system executive has included a strong emphasis on trans-disciplinarity and interprofessional initiatives. Her leadership efforts focus on collaborative bio-health research models, science education innovation and research technologies.

Dr. Hurn earned her BSN at the University of Florida, MN at the University of Washington, and PhD at Johns Hopkins University.

Dr. Johns currently serves as Professor in the Schools of Medicine and Public Health at Emory University. He is Executive Vice President for Health Affairs Emeritus at Emory University, and President, CEO, and Chairman of the Board Emeritus of Emory Healthcare – positions he held at Emory from 1996 to 2007. He also served as Emory’s Chancellor from 2007 to 2012. Prior to coming to Emory, Dr. Johns was Vice President of the Medical Faculty and Dean of the Johns Hopkins School of Medicine. He also served as interim Executive Vice President for Medical Affairs at the University of Michigan from June 2014 thru February 2015.

Dr. Johns received his bachelor's degree from Wayne State University and graduated with distinction from the University of Michigan Medical School. After completing his residency training in Otolaryngology/Head and Neck Surgery at Michigan, he joined the Medical Corps of the U.S. Army and was assistant chief of the Otolaryngology Service at Walter Reed Army Medical Center. In 1977, he joined the Department of Otolaryngology and Maxillofacial Surgery at the University of Virginia Medical Center, where he rose to the rank of Professor. In 1984, Dr. Johns was recruited to Johns Hopkins as professor and chair of Otolaryngology-Head and Neck Surgery.

Peter McCanna is chief executive officer (CEO) at Baylor Scott & White Health, the largest not- for-profit health system in Texas. The system’s integrated delivery network includes Baylor Scott & White Health Plan, Baylor Scott & White Research Institute, Baylor Scott & White Quality Alliance and its leading digital health platform, MyBSWHealth.

Through 51 hospitals and more than 1,100 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care, as well as an array of virtual and in-home services.

As CEO, McCanna leads the health system’s transformation to deliver experiences that go beyond customers’ traditional expectations of healthcare. Before becoming CEO, he served as Baylor Scott & White’s president, where he advanced clinical alignment, accelerated the development of its digital health strategy and expanded academic affiliations to help address the critical need for clinicians in Texas. 

Previously, McCanna served as executive vice president and chief operating officer at Northwestern Medicine. During his tenure, operating revenue, quality, patient experience and employee engagement exceeded targets. He was instrumental in Northwestern’s expansion as it maintained its AA+ bond rating.

McCanna has nearly 35 years of experience in healthcare management and consulting. Prior to joining Northwestern, he served as chief financial officer (CFO) at Presbyterian Healthcare Services in New Mexico and CFO at the University of Colorado Hospital in Denver. Earlier in his career, he worked for Denver Health and as a healthcare consultant for The Lewin Group.

He currently serves on the Board of Governors of Catholic Extension. McCanna holds a master’s degree from the Lyndon B. Johnson School of Public Affairs at the University of Texas at Austin and a bachelor’s degree in English from the University of Michigan.

Dr. Mark Prince is the Charles J. Krause M.D. Collegiate Professor of Otolaryngology and Chair of the Department of Otolaryngology – Head and Neck Surgery. After completing a degree in chemical engineering at the Technical University of Nova Scotia and earning his Medical Degree at Dalhousie University Medical School in Halifax, Nova Scotia, Dr. Prince went on to serve with the Canadian Armed Forces as a medical officer where he received specialized training in hyperbaric and diving medicine. Dr. Prince returned to Dalhousie University and completed a residency in Otolaryngology Head and Neck Surgery, followed by a two-year fellowship in advanced head and neck oncology and microvascular reconstructive surgery at the University of Michigan.

In 1998, Dr. Prince accepted an appointment at Dalhousie as an Assistant Professor and served as their Otolaryngology Residency Director before joining the University of Michigan faculty in 2000. He also served as the Chief of the Section of Otolaryngology at the Ann Arbor VA Medical Center from 2000 until 2014; he continues to serve there as an active part time staff member.

Dr. Prince is the author of over 160 scientific papers and several book chapters. His research laboratory published the first report of the identification of cancer stem cells in head and neck squamous cell cancer, and continues to conduct research in this exciting field. Dr. Prince also remains actively engaged in resident and medical student education, serving as the Otolaryngology department's Residency Program Director until 2016 and as the Associate Chair for Education from 2009-2016. He also served as the Assistant Dean for Graduate Medical Education until 2018 and continues to co-lead a collaborative education initiative with the ENT department at Komfo Anokye Teaching Hospital in Kumasi Ghana.

 

Bob is Co-Founder and Chairman of Bright Health Group, a technology enabled, value-based healthcare company that organizes and operates networks of affiliate care providers to be successful at managing population risk.  Before co-founding Bright Health in 2015, Bob advised private equity and venture capital firms on healthcare.   From 1986 to 2009, Bob held executive positions at United Health Group, becoming CEO of United Healthcare in 2000. 

Bob serves on the boards of Radiology Partners and Connections Health Solutions.  Radiology Partners is a national radiology practice transforming radiology for radiologists, radiology practices, hospitals, health systems, patients, and families.  Connections Health Solutions creates positive, lasting change in communities by providing immediate access to person-centered behavioral healthcare by improving clinical outcomes.

Bob earned his bachelors and master’s degrees from the University of Michigan.  He currently serves as Chair of the University of Michigan School of Public Health Dean’s Advisory Board.

Marianne Udow-Phillips is the Head of Public Health for Rewind, Principal of MuConsulting, Senior Advisor to the Center for Health and Research Transformation at the University of Michigan, and on faculty at the University of Michigan School of Public Health and Ford Public Policy School.  In her current roles, Marianne provides strategic consulting and mentorship to advance social justice, improve population health and strengthen the effectiveness of health, public health and mental health systems.

Marianne was the founding executive director of the Center for Health and Research Transformation (CHRT) at the University of Michigan. As an independent 501(c)(3) impact organization, CHRT works to advance evidence-based care delivery, improve population health, and expand access to care by transforming research and evidence into actionable policy approaches. Prior to her leadership role at CHRT, Marianne served as director of the State of Michigan’s Department of Human Services (2004-2007) where she oversaw services and programs—child support, food assistance, child welfare, juvenile justice, and public assistance--for Michigan’s most vulnerable citizens.

Marianne came to state service from Blue Cross Blue Shield of Michigan (BCBSM). At BCBSM, she served in leadership roles for more than 20 years and ended her service as senior vice president of health care products and provider services with responsibility for the organization’s social mission, health policy, data analysis, and care and network management programs. 

Marianne has served on numerous boards and commissions.  Her current boards include Arbor Research for Health, University of Michigan Health, Community Mental Health of Washtenaw County and the Grameen Foundation.  Current advisory boards include the State of Michigan Public Health Advisory Council, University of Michigan Depression Center, University of Michigan School of Public Health and Michigan Women Forward Emeritus Board. Prior governing or advisory boards include HighScope Educational Research Foundation, Dialogue Direct, Early Childhood Investment Corporation and Arboretum Ventures.

Marianne has received numerous awards and honors over the years including the Anti-Defamation League’s “Women of Achievement Award,” Crain’s Detroit Business’s top 100 “Most Influential Women Award,” the Michigan Women’s Foundation’s “Women of Achievement and Courage Award,” and the Michigan Children’s “Heroes” Award. Ambassador Magazine named her an Ambassador of the Year in 2011 and Crain’s Detroit Business named her a Woman in Business Game-Changer in 2012. 

Marianne holds a master’s degree in health services administration from the University of Michigan School of Public Health and serves as a lecturer for both the University of Michigan Gerald R. Ford School of Public Policy and School of Public Health.

Fionnuala Walsh, Ph.D. is a recognized thought leader in the quality industry, often speaking about sustainable, integrated quality systems and the importance of maintaining a quality culture. A native of Ireland, Walsh earned a bachelor's degree and doctoral degree in chemistry from University College Dublin. Prior to her time with Eli Lilly and Company, she was awarded an industrial postdoctoral fellowship with BMS in Puerto Rico and worked at a startup company manufacturing clinic material. She joined Lilly's Kinsale, Ireland, manufacturing site in 1988 as a technical services chemist. After numerous positions there, she moved into a role as global quality leader at the Lilly Corporate Center in Indianapolis in 2002. In January 2003, Walsh was named executive director of quality for U.S. drug product and Lilly Technology Center operations. In July 2005, she was named vice president of global quality operations, and, in June 2007, she was named senior vice president of global quality.